Neurology Flashcards

1
Q

Extrapyramidal triad of Parkinsonism

A
  • Tremor: worse at rest, ‘pill-rolling’
  • Hypertonia: rigidity + tremor, ‘cogwheel rigidity’
  • Bradykinesia: decrease blink rate, micrographia, decrease arm swing, expressionless face
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathology of Parkinson’s disease

A

Loss of dopaminergic neurons in substantia nigra in the basal ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Bamford stroke classification***

A

> TACS
All three:
- Unilateral weakness (and/or sensory deficit) of the face, arm and leg
- Homonymous hemianopia
- Higher cerebral dysfunction (dysphasia, visuospatial disorder)

> PACS
Two of following:
(Same as TACS)

> Lacunar syndrome
One of following:
- Pure sensory stroke
- Pure motor stroke
- Sensori-motor stroke
- Ataxic hemiparesis

> POCS
One of following:
- CN palsy and contralateral motor/ sensory deficit
- Bilateral motor/ sensory deficit
- Conjugated eye movement disorder (eg: gaze palsy)
- Cerebellar dysfunction (eg: ataxia, nystagmus, vertigo)
- Isolated homonymous hemianopia or cortical blindness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NIH Stroke Scale

A
  • Objective quantify severity of stroke
  • 11 components, all related to symptoms of stroke
  • Ranged from no stroke symptoms to severe stroke symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Contraindication for thrombolysis

A
> History
- Unclear time/ wake up stroke
- Within 3 months (prior ischemia stroke, recent head trauma, intracranial/ spine surgery)
- Recent birth, surgery, trauma
- Intracranial pathology
> Investigation
- BP >220/130
- Major infarct or hemorrhage on CT
- Coagulopathy (platelets <100 x 10*9/L, INR >1.7, aPTT >40s, PT >15s)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Monitoring of stroke

A
  • Admit stroke unit
  • BP and neurological examination
  • Every 15 min during and 2 hours after IV alteplase, then
  • Every 30 min for 6 hours, then
  • Hourly until the 24th hour
  • Maintain BP <180/105mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

History taking for stroke*

A
  • Onset (Important for management)
  • Visual disturbance
  • Speech disturbance
  • Headache
  • Sign of meningism (might indicate SAH)
  • Risk factor of stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Expected physical sign for stroke***

A

○ Cerebral infarct - 50%

  • Contralateral sensory loss or hemiplegia
  • Initially flaccid, becoming spastic
  • Dysphagia
  • Homonymous hemianopia

○ Brainstem - 25%

  • Quadriplegia
  • Disturbance of gaze and vision
  • Locked-in syndrome

○ Lacunar infarct - 25%

  • Ataxic hemiparesis
  • Pure motor
  • Pure sensory
  • Sensorimotor
  • Dysarthria/ clumsy hand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Investigation for stroke**

A

> ETD

  • CT brain: exclude ICH
  • Random blood glucose: hypoglycemia cause focal neurologic deficit mimicking stroke; hyperglycemia associate with worse outcome

> Work-up

  • FBC: exclude anemia, polycythemia, thrombocytosis, thrombocytopenia
  • Urea and electrolyte: hydration status, exclude electrolyte imbalance
  • Coagulopathy: as baseline if thrombolysis considered
  • CT angiogram
  • Echocardiogram: mural thrombus, hypokinetic segment, valvular lesion
  • 12- lead ECG, 24-hr hotler: AF
  • CXR: enlarged left atrium
  • Carotid doppler: carotid artery stenosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Immediate management for stroke***

A
  • Non-contrast CT brain
  • Monitor vital signs
  • Supportive treatment (O2, airway support, correct hypovolemia, maintain normothermia)
  • Monitor blood glucose (aim 6-10 mmol/L), NIHSS score, GCS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Definitive treatment for stroke***

A
  • Mechanical thrombectomy
  • Thrombolysis using tPa (eg: IV alteplase)

Post-thrombosis:
- CT 24h post-lysis to identify bleed before initiating antiplatelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Stroke unit care management**

A
  • Supplement O2, airway support
  • Swallowing test
  • DVT prophylaxis (DO NOT use compression stocking)
  • Monitoring and treatment of acute complication: cerebral edema, seizure, infection (eg: pneumonia, UTI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pathogenesis for Gullain Barre Syndrome*

A
  • “Molecular mimicry”
  • Typically Campylobacter jejuni, crosses react with ganglioside GM1 in the myelin
  • Other: CMV, EBV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Types of GBS

A

○ Acute inflammatory demyelinating polyneuropathy (AIDP)
- Acute variant of GBS

○ Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Chronic variant of GBS

○ Miller-Fisher syndrome
- With cranial nerve involvement

○ Multifocal motor neuropathy
- Only affect motor neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical features of GBS***

A
  • Lower motor neuron signs (areflexia is highly suggestive, wasting and weakness at distal muscles of hands and feet)
  • Shortness of breath (due to bulbar palsy and phrenic nerve involvement)
  • Distal numbness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigation of GBS**

A

○ DIAGNOSED CLINICALLY (No specific test)
○ Lumbar puncture: Albumin-cytologic dissociation - Hallmark of GBS (increase protein with normal WCC)
○ Nerve conduction studies: Demyelinating pattern, slow conduction
○ Forced vital capacity: Respiratory muscle may be compromised

17
Q

Management for GBS**

A
  • First line: IVIG
  • Mechanical ventilation if respiratory muscle are involved
  • Chest physiotherapy
18
Q

Triad of Miller-Fisher syndrome

A
  • Ophthalmoplegia
  • Ataxia
  • Areflexia
19
Q

Features in CT brain of ischemic stroke

A
  • Loss of insular ribbon
  • Hypoattenuation of brain tissue
  • Loss of sulcus and grey-white differentiation
  • Dense MCA
  • Obscuration of lentiform nucleus
20
Q

Causes of postural instability

A
  • Weakness and spasticity: central lesion or spinal cord disease
  • Foot drop: lumbar spinal stenosis
  • Apraxic gait: normal pressure hydrocephalus, neurodegenerative dementia
  • Narrow based gait: Parkinson’s disease
  • Vestibular gait: sensorineural vestibular disease
21
Q

Causes of stroke

A
  • Atherothrombosis
  • Embolism (eg: AF, infective endocarditis)
  • CNS bleed (eg: hypertension, trauma, aneurysm rupture, anticoagulant)
22
Q

Target INR for AF stroke prevention

A

2 to 3

23
Q

Risk factor for stroke***

A

> Non-modifiable

  • Age
  • Sex: Male
  • Family history

> Modifiable

  • Hypertension, DM
  • Smoking
  • Hypercholesterolemia
  • Peripheral vascular disease
  • Atrial fibrillation
24
Q

Management of hemorrhagic stroke

A
  • Severe hypertension should be lowered
    □ IV beta blocker, nicardipine, hydralazine, nitroglycerine
  • Reversal of anticoagulation
    □ Administration of fresh frozen plasma and vitamin K
    □ Antiplatelet and anticoagulation are contraindicated
  • Prevention of venous thromboembolism
    □ Intermittent pneumatic compression
  • If significant mass effect
    □ Surgical evacuation: >20ml in volume or a midline shift on CT scan
25
Q

Causes of young stroke

A
  • Atrial fibrillation
  • Arterial dissection
  • Thrombophilic disorders: protein C/ S deficiency, antiphospholipid syndrome
  • Acquired thrombophilic state: hormonal contraception, nephrotic syndrome
26
Q

Quick, early recognition of stroke

A

“FAST”

  • Facial dropping
  • Arm weakness
  • Speech difficulty
  • Time to call for ambulance!
27
Q

What to do if suspicious for subarachnoid hemorrhage but CT is normal

A
  • Arrange lumbar puncture after 12 hours

- Look for xanthochromia (presence of bilirubin in CSF due to break down of blood)

28
Q

Management of dementia

A
  • Cholinesterase inhibitors (eg: donepezil): reduce symptoms through increase cholinergic transmission by inhibiting cholinesterase at the synaptic cleft
  • NMDA receptor antagonist (eg: memantine): block pathologic stimulation of NMDA receptor against further damage in patient with vascular dementia